New approach to tackle alphavirus infections
Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections.
Feb 24, 2015
0
6
Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections.
Feb 24, 2015
0
6
(HealthDay)—The first test to screen for Severe Combined Immunodeficiency (SCID) in newborns has been approved by the U.S. Food and Drug Administration.
Dec 16, 2014
0
0
A US ban on blood donations by gays could be eased after 31 years, depending on the decision of a Food and Drug Administration advisory committee that began two days of meetings Tuesday.
Dec 2, 2014
0
0
(HealthDay)—Federal and local health officials said Monday that they were re-examining infection-control efforts at the Dallas hospital where a nurse contracted Ebola while caring for America's first diagnosed victim of ...
Oct 14, 2014
0
0
New York's JFK airport began strict new health screenings Saturday for travelers arriving from Ebola-hit West African nations, amid growing US fears about importing the deadly virus.
Oct 11, 2014
0
0
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) discovered that a protein named IL23A is part of our stomach's defence against bacterial infection ...
Jul 4, 2014
0
0
Antibodies and their derivatives can protect plants and animals—including humans—against viruses. Members of this class of drugs are usually highly specific against components of a particular virus, and mutations in the ...
Jun 26, 2014
0
0
Researchers at the Manchester Royal Infirmary's Diabetes Centre and Vascular Surgery Department together with microbiologists from The University of Manchester have recruited the first patient into a global study evaluating ...
Apr 8, 2014
0
0
Rutgers University scientists have determined the structure of a hepatitis C surface protein, a finding that could assist in the development of a vaccine to halt the spread of the the deadly disease that has infected 3.2 ...
Feb 19, 2014
0
0
With very few treatment options available to fight deadly mucormycosis infections, a new Los Angeles Biomedical Research Institute (LA BioMed) study holds hope for adding to the arsenal of therapies physicians have to combat ...
Feb 6, 2014
0
0